APA (7th ed.) Citation

V. I. Petrov, A. Y. Ryazanova, D. A. Nekrasov, V. I. Svinukhov, & N. S. Privaltseva. (2022). Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors. Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products».

Chicago Style (17th ed.) Citation

V. I. Petrov, A. Y. Ryazanova, D. A. Nekrasov, V. I. Svinukhov, and N. S. Privaltseva. Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors. Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022.

MLA (9th ed.) Citation

V. I. Petrov, et al. Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors. Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022.